Logo for Celularity Inc

Celularity Investor Relations Material

Latest events

Logo for Celularity Inc

Analyst Research & Development Day 2024

Celularity
Logo for Celularity

Q2 2025

29 Aug, 2025
Logo for Celularity

Q1 2025

29 Aug, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Celularity Inc

Access all reports
Celularity Inc. is a biotechnology company focused on developing off-the-shelf, placental-derived allogeneic cell therapies for treating cancer, immune, and infectious diseases. The company's core therapeutic products include genetically modified and unmodified natural killer (NK) cells, CAR-T cells, and mesenchymal-like adherent stromal cells. Additionally, Celularity produces placental-derived biomaterials used in various therapeutic applications. It operates through three main segments: Cell Therapy, Degenerative Disease, and BioBanking. The company is headquartered in Florham Park, New Jersey, and its shares are listed on NASDAQ.